• 13773 Citations
  • 45 h-Index
1978 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Tyler J Curiel is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.


Research Output

Chronic mechanistic target of rapamycin inhibition: Preventing cancer to delay aging or vice versa?

Hambright, H. G., Hurez, V. & Curiel, T. J., Jan 1 2020, Geriatric Oncology. Springer International Publishing, p. 111-128 18 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

  • Pparγ inhibition boosts efficacy of pd-l1 checkpoint blockade immunotherapy against murine melanoma in a sexually dimorphic manner

    Wu, B., Sun, X., Yuan, B., Ge, F., Gupta, H. B., Chiang, H. C., Li, J., Hu, Y., Curiel, T. J. & Li, R., 2020, In : International Journal of Biological Sciences. 16, 9, p. 1526-1535 10 p.

    Research output: Contribution to journalArticle

    Open Access
  • 1 Scopus citations

    Percutaneous BCG enhances innate effector antitumor cytotoxicity during treatment of bladder cancer: a translational clinical trial

    Ji, N., Mukherjee, N., Morales, E. E., Tomasini, M. E., Hurez, V., Curiel, T. J., Abate, G., Hoft, D. F., Zhao, X. R., Gelfond, J. A., Maiti, S., Cooper, L. J. N. & Svatek, R., Jan 1 2019, In : OncoImmunology.

    Research output: Contribution to journalArticle

  • 2 Scopus citations

    Rapamycin prevents surgery-induced immune dysfunction in patients with bladder cancer

    Svatek, R. S., Ji, N., De Leon, E., Mukherjee, N. Z., Kabra, A., Hurez, V., Nicolas, M. M., Michalek, J. E., Javors, M., Wheeler, K., Dave Sharp, Z., Livi, C. B., Shu, Z. J., Henkes, D. & Curiel, T. J., Mar 2019, In : Cancer Immunology Research. 7, 3, p. 466-475 10 p.

    Research output: Contribution to journalArticle

  • 3 Scopus citations

    Adipose PD-L1 Modulates PD-1/PD-L1 Checkpoint Blockade Immunotherapy Efficacy in Breast Cancer

    Wu, B., Sun, X., Gupta, H. B., Yuan, B., Li, J., Ge, F., Chiang, H. C., Zhang, X., Zhang, C., Zhang, D., Yang, J., Hu, Y., Curiel, T. J. & Li, R., Nov 2 2018, In : OncoImmunology. 7, 11, e1500107.

    Research output: Contribution to journalArticle

  • 13 Scopus citations